SureTrader
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

That said, of course I think the trial

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
tasgrewaf Member Profile
 
Followed By 9
Posts 573
Boards Moderated 0
Alias Born 05/01/11
160x600 placeholder
Amarin to Report Fourth Quarter and Full Year 2017 Results and Host Conference Call on February 27th, 2018 GlobeNewswire Inc. - 2/20/2018 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/1/2018 5:02:21 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/31/2018 5:27:59 PM
Amarin Prices Public Offering of American Depositary Shares GlobeNewswire Inc. - 1/30/2018 8:58:26 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/29/2018 4:08:42 PM
Amarin Announces Proposed Public Offering of American Depositary Shares GlobeNewswire Inc. - 1/29/2018 4:01:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/23/2018 6:01:14 PM
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark for Reported Primary Events GlobeNewswire Inc. - 1/23/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/17/2018 5:59:57 PM
Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China GlobeNewswire Inc. - 1/17/2018 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2018 6:01:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/9/2018 6:01:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/4/2018 4:57:25 PM
Amarin Provides Preliminary 2017 Results and Provides 2018 Outlook GlobeNewswire Inc. - 1/4/2018 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2018 4:34:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/2/2018 4:33:51 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 12/22/2017 4:13:13 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/21/2017 4:04:15 PM
Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018 GlobeNewswire Inc. - 12/19/2017 6:00:00 AM
Amarin to Present at 36th Annual J.P. Morgan Healthcare Conference in San Francisco GlobeNewswire Inc. - 12/18/2017 4:30:00 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 12/4/2017 4:48:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/4/2017 9:04:12 AM
Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular ... GlobeNewswire Inc. - 11/14/2017 4:30:00 PM
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin Treated Pat... GlobeNewswire Inc. - 11/13/2017 4:30:00 PM
Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical ... GlobeNewswire Inc. - 11/13/2017 6:00:00 AM
tasgrewaf   Friday, 10/06/17 11:03:59 AM
Re: iwfal post# 115618
Post # of 122983 
Quote:
That said, of course I think the trial has a LOT of risk. In a way very similar to ONTY



I don't disagree. I really like the inflammation theory here, but it's a theory.

The thing I like better here is that this is not an oncology play.

I have had it with chasing oncology plays!

“The trick is in what one emphasizes. We either make ourselves miserable, or we make ourselves happy. The amount of work is the same.” Carlos Castaneda
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist